BigFirst uses genetics and brain scans to split MCI patients into low-risk and high-risk subtypes, claiming faster progression and distinct biomarker profiles in the high-risk group.
Alzh eimer’s & dementia 14(4), 535–562 (2018)
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
q-bio.QM 1years
2025 1verdicts
CONDITIONAL 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Comprehensively stratifying MCIs into distinct risk subtypes based on brain imaging genetics fusion learning
BigFirst uses genetics and brain scans to split MCI patients into low-risk and high-risk subtypes, claiming faster progression and distinct biomarker profiles in the high-risk group.